Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Chiroscience reports PDE/TNF inhibitors

July 30, 1997

Sepracor reports promising phase II results for norastemizole

July 29, 1997

Genelabs and UCSF sign agreement for asthma clinical study

July 28, 1997

FDA health advisory for Accolate

July 25, 1997

Piperidone and glutarimide neurokinin antagonists developed at Pfizer

July 25, 1997

Antiallergic and bronchodilating effects of KF-19514 in guinea pigs

July 21, 1997

NK3/NK2 receptor antagonists from SmithKline Beecham

July 21, 1997

SmithKline Beecham discloses selective, nonpeptide NK3 antagonists

July 21, 1997

Eisai discloses acridone antiallergy agents

July 18, 1997

Leukotriene antagonists prepared by Leo

July 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...